High metallothionein predicts poor survival in glioblastoma multiforme

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. METHODS: We performed whole genome expr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Med Genomics
Asıl Yazarlar: Mehrian-Shai, Ruty, Yalon, Michal, Simon, Amos J., Eyal, Eran, Pismenyuk, Tatyana, Moshe, Itai, Constantini, Shlomi, Toren, Amos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4618994/
https://ncbi.nlm.nih.gov/pubmed/26493598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-015-0137-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller